UBS O'Connor’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

UBS O'Connor’s Portfolio FRBN Stock Details FRBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-181,263	Closed	-$1.99M	–	663
2023 Q3	$1.99M	Hold	181,263	–	–	0.04%	243
2023 Q2	$1.94M	Sell	181,263 -4,086	-2%	-$43.3K	0.04%	296
2023 Q1	$1.95M	Buy	+185,349	New	+$1.93M	0.05%	316
2022 Q4	–	Sell	-187,163	Closed	-$1.9M	–	565
2022 Q3	$1.9M	Sell	187,163 -18,737	-9%	-$188K	0.02%	640
2022 Q2	$2.06M	Buy	+205,900	New	+$2.05M	0.02%	642

UBS O'Connor's FRBN Position: Q4 2023 in Review

UBS O'Connor sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2023, closing a stake of 181,263 shares — an estimated $1.99M sold.

UBS O'Connor first reported a position in FRBN in Q2 2022 and held it in 5 quarters. The position peaked at $2.06M in Q2 2022. 0 funds tracked by Wall St. Rank hold FRBN as of Q4 2023.

UBS O'Connor reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
UBS O'Connor sold 181,263 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $1.99M.
UBS O'Connor first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 5 quarters.
UBS O'Connor's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $2.06M in Q2 2022.
0 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.